Clinical Trials Logo

Clinical Trial Summary

A placebo controlled clinical trial investigating the safety and immunogenicity of GBS6 in pregnant women with and without human immunodeficiency virus (HIV) infection and their infants


Clinical Trial Description

This Phase 2, randomised, placebo controlled, double blinded study will be the first evaluation of the investigational GBS6 in HIV-infected pregnant women. This study will enroll pregnant women with and without HIV to receive GBS6 or Placebo in order to provide an expanded safety and immunogenicity data set (for both pregnant women and their infants) and to support progression of the development of this vaccine. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05832502
Study type Interventional
Source St George's, University of London
Contact
Status Active, not recruiting
Phase Phase 2
Start date October 14, 2022
Completion date September 30, 2025

See also
  Status Clinical Trial Phase
Completed NCT02142933 - Simplified GBS Screening and Prevalence of ESBL in Pregnant Women N/A
Completed NCT04596878 - Study of a Group B Streptococcus Vaccine in Pregnant Women Living With HIV and in Pregnant Women Who do Not Have HIV Phase 2
Withdrawn NCT04116645 - Time Frame for GBS Screening
Terminated NCT02814318 - Intrapartum Effect of Vancomycin on Rectovaginal GBS Colonization
Withdrawn NCT04227730 - MATERNAL AND NEONATAL SCREENING FOR GROUP B STREPTOCOCCI : A Follow up STUDY
Completed NCT05154578 - Immunogenicity and Safety of GBS-NN/NN2 in Pregnant Women Phase 2
Completed NCT02528981 - Effect of Probiotics on GBS Colonization Status During Pregnancy: A Pilot Randomized Controlled Trial N/A
Recruiting NCT01577108 - Oral Probiotics Reduce Group B Streptococci Colonization in Pregnant Women Phase 2